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Abstract
In rats, various growth factors and hormones, as well
as partial hepatectomy (PH) are able to trigger the
proliferative response of hepatocytes. Although recent
evidence highlights the important role of thyroid
hormones and thyroid status in regulating the growth
of liver cells in vitro and in vivo models, the mechanism
involved in the pro-proliferative effects of thyroid
hormones is still unclear. Here we have investigated
how in rats made hypo- and hyperthyroid after
prolonged treatment respectively with propylthiouracil
(PTU) and triiodothyronine (T3), the thyroid status
affects liver regeneration after PH by regulating cell
cycle and apoptosis proteins. Our results show that
both in control and partially hepatectomized animals
hyperthyroidism increases the cyclin D1, E and A
levels and the activity of cyclin-cdk complexes, and
decreases the levels of cdk inhibitors such as p16
and p27. On the contrary hypothyroidism induces a
down-regulation of the activity of cyclin cdk complexes
decreasing cyclin levels. Thyroid hormones control
also p53 and p73, two proteins involved in apoptosis
and growth arrest which are induced by PH. In
particular, hypothyroidism increases and T3 treatment
decreases p73 levels. The analysis of the
phosphorylated forms of p42/44 and p38 MAPK
revealed that they are induced during hepatic
regeneration in euthyroid and hyperthyroid rats
whereas they are negatively regulated in hypothyroid
rats. In conclusion our data demonstrate that thyroid
status can affects liver regeneration, altering the
expression and the activity of the proteins involved in
the control of cell cycle and growth arrest.
Introduction
Liver regeneration is a complex process controlled
by multiple signaling pathways induced by a variety of
hormones, growth factors and cytokines [1-3].
Differentiated hepatocytes rapidly re-enter the cell cycle
after 2/3 partial hepatectomy (PH) and the restoration of
the original and functional liver mass occurs within 2
weeks [4]. This regenerative response of liver, considered
as compensatory hyperplasia, is a result of the action of
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different substances able to provoke a perfect balance
between cell proliferation and apoptosis. During the first
hours after PH, tumor necrosis factor-α (TNFα) and
interleukin-6 (IL-6) activate the DNA-binding of
transcription factors, such as signal transducer and
activator of transcription 3 (STAT3) [5-7], and induce an
increased expression of c-myc, c-fos, and c-jun [8, 9].
Besides the pivotal role of STAT3, also p42/44 mitogen-
activated protein kinase (p42/44 MAPK) and p38 MAPK
are able to affect cellular growth, transformation,
differentiation and apoptosis in rat liver [10-12].
Hepatocytes can also be stimulated to proliferate
by primary mitogens in the absence of liver injury or
resection resulting in an increase of liver mass greater
than the normal value. Liver mass subsequently returns
to its normal value following removal of the mitogenic
stimulus through apoptotic deletion of excess cells. One
of the most relevant apoptotic pathways is regulated by
proteins such as p53 and p73. Different roles for p53
related proteins have been postulated in regulating G1/S
transition, growth arrest, apoptosis, differentiation, and
DNA repair [13]. In particular, p53 and p73 activate similar
target genes, including p21waf-1, [14, 15] and induce
apoptosis and cell cycle arrest. p53, but not p73, is
considered a tumor suppressor gene, in fact p73 is over-
expressed by a subset of hepatocarcinoma and could
serve as a useful indicator of prognosis in patients with
this disease [16, 17].
It has been shown that several growth factors are
able to induce liver hyperplasia by regulating the levels
and the activities of different cyclin-dependent kinase
complexes [18-20] In the mammalian cells the sequential
activation of cyclin D1-cdk4/6, cyclin E-cdk2 and cyclin
A-cdk2 is associated with the middle-G1 phase, G1/S
transition and S phase respectively. The critical
determinants for the activity of cyclin-cdk complexes are
the tyrosine and threonine phosphorylation by cdk
activating kinases and the interaction with cdk inhibitors
[21, 22]. The proliferation of hepatocytes is often
correlated with the expression of cyclin D1 suggesting
that the regulation of cyclin D1 expression is critical for
the proliferation and differentiation of hepatocytes [23,
24]. Furthermore, we have demonstrated that the
treatment with EGF provokes an alteration in the timing
of S phase, acting especially on the activity of cyclin E/
A-cdk2 complexes in regenerating liver [25].
It has been demonstrated that also triiodothyronine
(T3) induces hepatocytes proliferation and gene
expression in vivo and in vitro [26], and it is able to
substitute PH in stimulating re-growth of transplanted
hepatocytes [27-28]. We have recently demonstrated that
thyroid hormones stimulate DNA-synthesis by activating
protein kinase C (PKC) and MAPK-dependent pathways
that influence the expression and the activity of proteins
controlling G1 and S phases of the cell cycle [29].
However, although it has been demonstrated that
hypothyroidism and hyperthyroidism can influence liver
regenerative response [30] and the course of some
hepatic injuries [31, 32], the role of thyroid status and T3
in regulating liver growth remains unexplored. The
comprehension of the mechanism that underlies the
mitogenic capacity of T3 could represent an important
advance in developing potentially useful methods to
stimulate liver repopulation after transplantation.
In a previous work we have demonstrated that
hypothyroidism delayed regeneration process [28], in fact
1 week after PH PTU treated animals recover only 46%
of liver mass whereas control animals regained 78%. In
this study, we investigate whether the effect of thyroid
status on liver regeneration is obtained by altering the
expression and the activity of cell cycle- or apoptosis-
related proteins. Our findings demonstrated that the
altered thyroid status affects the entry into S phase of
hepatocytes and the activities of cyclin cdk complexes
modifying the levels of D1, E and A cyclins and p16 and
p27 inhibitors. Furthermore, interesting results indicate
that the biochemical mechanisms by which thyroid status
influences the regenerative ability of liver require the




Male Wistar rats (Charles River, Milano, Italy) weighing
120-140 g at the start of the experiment were housed under
conditions of controlled temperature and light. The animals’
maintenance and treatment were carried out according to
national guidelines for animal care and use. Hypothyroidism
was chemically induced by a 6-week treatment with 0.95% PTU
added to the drinking water. Hyperthyroidism was induced by
daily intraperitoneal injection of T3, given at the dose of 15 µg/
100g body weight, for 1 week before PH. 70 % PH was performed
under pentobarbital anaesthesia and aseptic conditions
according to Higgins and Anderson [33]. The excised tissue
was used as non-regenerating liver. Rats were killed by cervical
dislocation at 12 and 24 hrs from surgery. Blood was collected
and allowed to clot and serum was stored at -80°C. Serum T3
and thyroxine (T4) were evaluated by an enhanced
chemiluminescence (ECL) enzyme immunoassay (Diagnostic
Products Corporation, Los Angeles, CA). The detection limit
of the assay was 0.35 ng/ml for T3 and 4 ng/ml for T4.
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Immediately after death, livers were quickly frozen in liquid
nitrogen and stored at -80°C until used.
Gel electrophoresis and Western blot
100 mg of liver tissues were minced and sonicated in
600 µl of lysis buffer (50 mM Tris/HCl [pH 7.5], 150 mM NaCl,
50 mM NaF, 5 mM EDTA, 1 % Triton X-100, 0.5 % sodium
deoxycholate, 1 mM phenyl-methyl sulfonylfluoride (PMSF),
0.2 mM leupeptin, and 1 mM sodium orthovanadate). Lysates
were then clarified by centrifugation for 1 minute at 13,000 rpm.
Protein concentration was measured by Lowry’s procedure [34].
200 µg of sample proteins were subjected to 7.5, 10 or 12.5 %
SDS-PAGE and transferred onto nitrocellulose membranes (Bio-
Rad Laboratories, Hercules, CA). The membranes were
preincubated in Tris-buffer saline (TBS) containing 5 % BSA
or defatted dried milk powder for 2 hrs at room temperature,
and then probed with a specific primary antibody for 2-3 hrs
(see below). Antibody reaction was revealed after incubation
for 45 minutes with alkaline phosphatase (Sigma Chemical Co.,
St. Louis, Mo.) or with conjugated horseradish peroxidase
(Santa Cruz Biotechnology, D.B.A. Italy) secondary antibody.
Immunoelectrophoretic profile was visualised using NBT/BCIP
reaction or a chemiluminescent method (ECL kit purchased from
Amersham, Buckingamshire, U.K.).
Antibodies
Membranes were probed with mouse monoclonal anti-
PCNA, rabbit policlonal anti-p42/44 MAPK and anti-p42/44
MAPK-activated all from Sigma. Mouse monoclonal anti-pp38
(sc-7973), rabbit polyclonal anti-cyclin A (sc-751), anti-cyclin E
(sc-481), anti-cyclin D1 (sc-753), anti-p16 (sc-1623), anti-p27
(sc-528), anti-cdk4 (sc-260), anti-cdk2 (sc-163), and goat
polyclonal anti-p21 (sc-397), anti-p53 (sc-6243), anti-p38 (sc-
535) all from Santa Cruz Biotechnology. Mouse monoclonal
anti-p73 ER15 antibody was obtained from Oncogene Science.
Kinase activity experiments were performed using mouse
monoclonal anti-cyclin D1 (sc-450) and rabbit polyclonal anti-
cyclin A (sc-751) and anti-cyclin E (sc-481).
Immunoprecipitation and cyclin-cdk complex activity
assay
100 mg of liver were homogenized in 1 ml of ice-cold Ripa
buffer (50 mM Tris/HCl [pH 7.4], 1 mM phenyl-
methylsulfonylfluoride, 40 mg of aprotinin per ml, 0.5 mM
sodium orthovanadate, 1 % Triton X-100, 0.1 % [β] 2-
mercaptoethanol. Homogenates were clarified by centrifugation
(12,000 rpm, 5 min, 4°C). Clarified homogenates (0.5 ml; 2 mg of
total proteins) were mixed with protein A-agarose and incubated
overnight at 4°C with primary antibody. Protein A-agarose was
recovered by centrifugation, the supernatant was discarded,
and the immunocomplexes were washed and used for kinase
assays or resuspended in sample buffer and prepared for SDS-
PAGE. Briefly, for kinase assays, immunocomplexes were
incubated, for 30 minutes at 30°C, with kinase reaction buffer
[18], supplemented with 5µg GST-Rb (retinoblastoma GST-
conjugated) fusion protein (Santa Cruz Biotechnology) or 3µg
histone H1 (Boerhinger, Mannheim, Germany), 20 µM
adenosine triphosphate (ATP), and 5 µCi [γ-32 P]-ATP
(Amersham 3,000 Ci/mM). After 30 minutes of incubation at
30°C, the samples were separated by 10 % SDS-PAGE. The
gels were dried and the phosphorylated proteins were detected
by autoradiography. Coomassie staining of gel was used to
control protein loading. Phosphorylated proteins were
quantified by Phoretix 1D software.
Statistical Analysis
The values in the figures are means ± SD. Data of cyclin-
cdk complex activity were analyzed by Student’s t test. A P
value less than 0.05 was considered statistically significant.
Results
Thyroid hormone modulation of PCNA levels
during hepatic regeneration
Firstly, we have examined serum thyroid hormone
levels in rats as described in Materials and Methods
section (fig. 1A). In euthyroid control rats, serum thyroid
hormone levels are T3=0.65±0.02 ng/ml, T4=57.28±3.01
ng/ml. Daily T3 administration to euthyroid rats for 1 week
before PH produces a hypertriiodothyroninemia with low
T4 serum concentration (T3=2.02±0.31 ng/ml, T4<4 ng/
ml). The administration of PTU to euthyroid rats for 6
weeks induces hypothyroidism with low serum levels of
thyroid hormones (T3=0.35±0.02 ng/ml, T4<4 ng/ml). The
decrease in thyroid hormone levels results in impaired
body growth and liver regeneration [28]. To assess the
effects of thyroid hormones on S phase entry we analysed
PCNA expression. PCNA is a nuclear protein expressed
differentially during the cell cycle. Since we had previously
demonstrated that PCNA levels increase rapidly in late-
G1 (12 hrs) and S phase (24 hrs) during hepatic
regeneration in rat [25], here we investigated whether
rats with an altered thyroid status can show changes in
the expression profile of PCNA. For the experiments we
used rats, made hypo- and hyperthyroid by treatment with
PTU for a month or T3 for one week. To analyse changes
occurring during hepatic regeneration, the operated
animals were killed at 12 and 24 hrs after PH. Sham
operated rat livers showed the same results of the control
(data not shown). As demonstrated in figure 1b, thyroid
status influences the expression of PCNA, indeed, we
observe that in non-regenerating livers, the treatment with
PTU or T3 respectively, down-regulates or up-regulates
the levels of PCNA with respect to controls. Interestingly,
the hypo- and hyperthyroidism modify the profile of PCNA
expression typical of partial hepatectomy. In particular,
PCNA amount in PTU-treated is lower than in normal
hepatectomized rats, both at 12 and 24 hrs, whereas in
T3-treated rats it is higher at 24 hrs.
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Fig. 1. Serum levels of thyroid hormones and the effects of
thyroid status on DNA-synthesis. A) Serum levels of thyroid
hormones in euthyroid (C), hypothyroid (PTU) and
hyperthyroid (T3) rats. Levels of thyroid hormones (T3 and
T4) were evaluated by an enhanced chemiluminescence enzyme
immunoassay. Data, expressed as ng/ml (means ± S.D.), were
obtained from ten different experiments. * P< 0.001, ** P< 0.01
vs. C; Student’s t test. B) Time course of PCNA expression in
non-regenerating and regenerating rat livers in the presence or
absence of PTU or T3 treatment. PCNA levels were analysed
by Western blotting. In the upper and lower panels we have
described the treatment of animals: non-hepactemized (lanes 1,
2, 3) or hepatectomized (lanes 4-9) rats treated with PTU (lanes
2, 5, 8), or T3 (lanes 3, 6, 9) as described in Materials and
Methods. The different time points after partial hepatectomy
are also indicated (upper panel). The immunoblot is
representative of three different experiments.
Thyroid hormone effects on the levels of cell cycle
regulatory proteins
Our first aim was to determine the levels of the
cyclins involved in the regulation of the late G1 phase
G1/S transition and S phase, in the different experimental
conditions analysed. When we compare the levels of all
cyclins in rats with different thyroid status, we observe
that the levels of cyclin D1, A and E are lower in
hypothyroid rats and higher in hyperthyroid rats with
respect to controls (fig. 2A). As reported in figure 2a,
regeneration is able to increase cyclin D1, A and E at 12
and 24 hrs, hypothyroidism however keeps the expression
levels of these proteins lower, whereas hyperthyroidism
significantly increases their amount. On the contrary, the
western blotting analysis of cdk4 and cdk2 (fig.  2B) shows
that the levels of these proteins remain unaltered in all
the experimental conditions. Finally we performed western
blot analysis of some cdks inhibitors, such as p16, p21
Fig. 2. Effects of thyroid status on the expression of cell cycle
regulatory proteins. The expression of proteins in lysates was
determined by Western blot analysis. The animals were treated
in vivo as described in the legend to figure1. A) Expression
profile of cyclin D1, cyclin E and cyclin A. B) Protein expression
levels of cdk4 and cdk2. C) Expression profile of cdk inhibitors:
p16, p21 and p27. Red Ponceau staining (data not shown)
confirms equal loading of membranes. Representative
immunoblots of three independent experiments are reported.
and p27 (fig. 2C). In normal rats only p16 and p27 are
detectable and their expression is reduced in hyperthyroid
rats, whereas p21 levels are increased in both
hyperthyroidism and hypothyroidism. During hepatic
regeneration after PH, there is an evident upregulation
of p21 expression, which is not influenced by thyroid
conditions. Differently, p16, that is weakly down-regulated
after 24 hrs from PH, is increased in hypothyroid rats.
On the contrary the level of p27, that decreases during
hepatic regeneration (especially at 12 hrs), is altered both
in hypothyroidism and hyperthyroidism.
Thyroid hormone effects on cyclin-cdk complex
activities
Changes in the levels of proteins is often unable to
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study the effect of thyroid status on the activity of cyclin-
cdk complexes involved in control of G1/S transition, we
performed different kinase assays as described in Material
and Methods section. Figure 3 (A, upper panel) shows
the results of the autoradiography of the cyclin D1-cdk4
activity. This activity, measured by retinoblastoma (Rb)
phosphorylation assay, results unchanged in control and
hypothyroid rats and it is enhanced in hyperthyroid rats.
During hepatic regeneration the activity of cyclin D1-
cdk4 complex is up-regulated, with a peak at 12 hrs after
PH, both in euthyroid and in hyperthyroid animals, whereas
hypothyroidism down-regulates the activity of this
complex. To analyse the activity of the cyclin E/A-cdk2
complexes we performed a histone H1 phosphorylation
assay. As shown in figure 3A the behaviour of these
cyclin-cdk complexes resembles the regulation of the
cyclin D1-cdk4 complex activity indicating that thyroid
status influence also the activity of cyclin E/A-cdk2
complexes.
Thyroid hormone effects on p53 and p73 proteins
Based on gene sequence homologies, a p53 gene
family becomes apparent with the addition of the most
recently identified p63 and p73 genes to the already known
p53. These genes encode for different p53 proteins and
multiple p63 and p73 isoforms. Actually, it is known that
both p53 and p73 proteins elicit tumor suppressor gene
properties that mediate cell cycle arrest or apoptosis after
DNA damage [13].
We investigated the effect of thyroid status on p53
and p73, two major proteins that regulate cell growth arrest
and apoptosis. Western blot analysis (fig. 4), demonstrates
that the amount of both p53 and p73 increases during
liver regeneration especially 12 hrs after PH. This result
is consistent with the notion that these proteins are up-
regulated during G1/S transition [35]. Interestingly, thyroid
status radically influences the expression of p53 and p73
in control and partially hepatectomized rats. In particular,
our results show that hyperthyroidism, both in non-
hepactomized and hepatectomized rats, doesn’t change
the expression of p53, whereas provokes a down-
regulation of p73. On the other hand, hypothyroidism
induces a down-regulation of the p53 expression levels
whereas it up-regulates the p73 expression levels.
Thyroid hormone effects on p42/44 MAPK and
p38 MAPK
Since the activity of p42/44 MAPK and p38 MAPK
often seems to be involved in regulating cell proliferation
and growth arrest during hepatic regeneration, we
analysed the effect of thyroid status on these two signal
mediators. Changes in the levels of both unphosphorylated
and phosphorylated (active) form of p42/44 MAPK and
p38 MAPK were analysed by western blotting. As
demonstrated in figure 5a, neither PH nor hyperthyroidism
seem to affect the expression levels of p42/44 MAPK
whereas hypothyroidism highly depresses the amount of
this kinase especially at 24 hrs after PH. Conversely, the
B
Fig. 3. Activity of cdks in rat liver regeneration is affect by
thyroid status. The animals were treated in vivo as described
in the legend to figure1. Liver tissue extracts were subjected to
immunoprecipitation/kinase assays as described in Materials
and Methods. A) The activity of cyclin D1-cdk4 complex was
performed by immunoprecipitation of cyclin D1 and revealing
for GST-pRb-phosphorylated form (upper panel). The activities
of cyclin E-cdk2 (middle panel) and the cyclin A-cdk2 complexes
(lower panel) were obtained using histone H1 as exogenous
substrate. The results of each assay were validated using a
control condition in which we omitted the antibody in the IP
reaction (data not shown). B) Histograms represent densito-
metric analysis by
Phoretix 1D software.
Data, expressed as ar-
bitrary units (means ±
S.D.), were obtained
from four different ex-
periments. * P< 0.001,
** P< 0.01 vs. control
or PH; Student’s t test.
A
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Fig. 4. Effects of thyroid status on the expression of pro-
apoptotic proteins. The expression of p53 and p73 was analysed
by Western blotting in rats treated as described in the legend
to figure1. Expression profile of p53 (upper panel) and p73 (lower
panel) is reported. Red Ponceau staining (data not shown)
confirms equal loading of membranes. Representative results
of three experiments are reported.
Fig. 5. Effects of thyroid status on the activity of p42/44 and
p38 MAPKs. The expression of proteins in lysates was
determined by Western blot analysis. The animals were treated
in vivo as described in the legend to figure1. A) Expression
profile of unphosphorylated form (upper panel) and
phosphorylated form (lower panel) of p42/44 MAPK. B) Protein
expression levels of unphosphorylated form (upper panel) and
phosphorylated form (lower panel) of p38 MAPK.
Representative immunoblots of three independent experiments
are reported.
analysis of the phosphorylated form of p42/44 MAPK
revealed that it increased during hepatic regeneration in
euthyroid and hyperthyroid rats, whereas, according to
previous results, it is negatively regulated in hypothyroid
rats during PH. The same analysis was also performed
to investigate p38 MAPK. As shown in figure 5B, in all
experimental conditions there aren’t any relevant changes
in the expression levels of the unphosphorylated form of
p38 MAPK. On the contrary, the analysis of the
phosphorylated form revealed that p38 is influenced by
PH and thyroid status. In particular, we observed that
hypothyroidism decreases whereas hyperthyroidism, as
PH (especially at 12 hrs), increases the activated form
of this kinase.
Discussion
As already described, even though differentiated
hepatocytes in adult liver are quiescent, several stimuli
(such as PH), induce their proliferation. The rapidly
proliferating cells in a regenerating liver are extremely
susceptible to carcinogenesis, as there is minimal time
available for DNA repair between two consecutive cell
cycles [36, 37]. It has been demonstrated that a single
dose of T3 enhances DNA-synthesis and regenerative
capacity of the liver after PH [38, 39]. Consistent with
these findings, recently it has been reported that although
hypothyroid rats are able to regenerate their liver mass
completely, the recovery is significantly delayed;  whereas
T3 administration to hypothyroid rats restores the liver
regenerative capacity [40].
Interestingly, Pibiri et al., [41] have found that when
T3 is administered to rats it causes an accelerated onset
of DNA-synthesis associated with a more rapid increase
of cyclin D1 and E expression, compared with partial
hepatectomy.Furthermore, we have demonstrated that,
during hepatic regeneration, thyroid status affects liver
regeneration by altering: liver regeneration index, DNA-
synthesis and poly (ADP-ribose) polymerase activity,
which influence DNA replication and repair, cell
differentiation and transformation [28]. Therefore, the
evaluation of the possible effects of the thyroid status on
liver ability to respond to the pro-proliferative stimuli of
PH, could be a very relevant model for understanding
the dynamics of the cell cycle.
In our study, we demonstrate that hypothyroidism
and hyperthyroidism act on the entry in to S phase of
hepatocytes as demonstrated by PCNA expression levels
confirming previous data on the effect of T3 on thymidine
incorporation [28]. This effect probably depends on the
expression levels and activity of cell cycle proteins involved
in G1 and S phases control, both in regenerating and non-
regenerating livers. Our results indicate that
hypothyroidism inhibits cell cycle progression depressing
the activity of cyclin-cdks complexes involved in the
control of G1/S transition, whereas hyperthyroidism
seems to induce the S phase progression by a sustained
A
B
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activation of cyclin-cdk complexes. These data confirm
the results of Pibiri [41] on the levels of cyclin D1 and
demonstrate that thyroid status may regulate cell cycle
progression also acting on the expression of p16 and p27
cdk inhibitor and on cyclin E/A-cdk2 complex activities
underlying that for liver re-growth, physiological levels of
thyroid hormones are needed.
Liver re-growth that occurs in response to PH
depends on a balance between proliferative and apoptotic
processes [3]. Some authors have demonstrated that the
expression of p53 is up-regulated in the regenerating liver
after PH [42] and in this context it seems to act as a
negative regulator of proliferation by providing cell cycle
checkpoint activity [43]. As concerns p73, its behaviour
and its role during liver regeneration is still unknown, but
recently it has been shown that p73 is regulated during
cell cycle and may be a target of the mitotic cyclin-cdk
complex [35, 43]. Our results demonstrate an up-
regulation of p73 confirming that apoptosis and growth
events are well regulated during hepatic regeneration.
Interestingly, this balance is altered by either thyroid
hormone treatment or withdrawal. In fact, the levels of
p73 slightly decrease in partially hepactomized
hyperthyroid rats, whereas they are significantly up-
regulated in partially hepatectomized hypothyroid rats with
respect to controls. These data indicate that the reduced
regenerative response occurring in hypothyroidism can
be caused not only by a reduced activity of cell cycle
regulating complexes, but also by an increased expression
of p73 involved in growth arrest. On the contrary the
data about p53 levels show only a little increase after PH
and T3-treatment without any significant alteration in
hypothyroidism.
Some reports suggest that p38 MAPK promotes
DNA-synthesis in regenerating hepatocytes, whereas
chronic activation of p42/44 MAPK has been shown to
lead to cellular growth arrest [10, 11]. Moreover it has
been demonstrated that thyroid hormones are also able
to activate p42/44 MAPK-dependent signal transduction
pathway [44-47]. Our results clearly indicate that thyroid
hormones as partial hepatectomy influence the activity
of these kinases, providing an additional clue to indicate
that these pathways are both involved in the regulation of
cell proliferation in liver. Furthermore, the negative
regulation of the p42/44 MAPK expression and activity
at 24 hrs after PH in hypothyroid rats, may suggest an
interesting role of thyroid hormones in modulating the
expression or degradation of this kinase.
In conclusion, we found that the thyroid status could
affect the regenerative capacity of liver, altering the levels
and the activities of proteins involved in the control of
cell cycle progression and growth arrest. These changes
in control liver cells homeostasis suggest that thyroid
functionality could be an important parameter not only to
determine the good-end of liver transplantation but also
to evaluate the possible development of liver neoplasia
during regenerative process, thus further genetic
approaches (i.e. siRNA) could be useful to demonstrate
a causal relation between cell cycle and/or apoptosis genes
and the effect of thyroid hormones on liver.
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